Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia.
Saved in:
| Title: | Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia. |
|---|---|
| Authors: | Liegel J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Stroopinsky D; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Cheloni G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Karagkouni D; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Nahas M; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Ma Y; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Torres D; Beth Israel Deaconess Medical Center, Boston, MA., Saldarriaga I; Beth Israel Deaconess Medical Center, Boston, MA., Wang S; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Arruda de Amaral A; Beth Israel Deaconess Medical Center, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Ploumakis A; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Clohessy J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Abirached J; Beth Israel Deaconess Medical Center, Boston, MA., Bisharat L; Beth Israel Deaconess Medical Center, Boston, MA., Fraenkel P; Sanofi, Cambridge, MA., Yildirim O; Sanofi, Cambridge, MA., Bonnevaux H; Sanofi, Paris, France., Guerif S; Sanofi, Paris, France., Rallis K; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Chedid G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Vlachos IS; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Avigan D; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Rosenblatt J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. |
| Source: | Blood advances [Blood Adv] 2025 Nov 11; Vol. 9 (21), pp. 5585-5597. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40811786 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liegel+J%22">Liegel J</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Stroopinsky+D%22">Stroopinsky D</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cheloni+G%22">Cheloni G</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Karagkouni+D%22">Karagkouni D</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Nahas+M%22">Nahas M</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Torres+D%22">Torres D</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Saldarriaga+I%22">Saldarriaga I</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Arruda+de+Amaral+A%22">Arruda de Amaral A</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ploumakis+A%22">Ploumakis A</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Clohessy+J%22">Clohessy J</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Abirached+J%22">Abirached J</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bisharat+L%22">Bisharat L</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Fraenkel+P%22">Fraenkel P</searchLink>; Sanofi, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Yildirim+O%22">Yildirim O</searchLink>; Sanofi, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Bonnevaux+H%22">Bonnevaux H</searchLink>; Sanofi, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guerif+S%22">Guerif S</searchLink>; Sanofi, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rallis+K%22">Rallis K</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chedid+G%22">Chedid G</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Kufe+D%22">Kufe D</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Vlachos+IS%22">Vlachos IS</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Avigan+D%22">Avigan D</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Rosenblatt+J%22">Rosenblatt J</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Nov 11; Vol. 9 (21), pp. 5585-5597. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40811786 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2024015449 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5585 Titles: – TitleFull: Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liegel J – PersonEntity: Name: NameFull: Stroopinsky D – PersonEntity: Name: NameFull: Cheloni G – PersonEntity: Name: NameFull: Karagkouni D – PersonEntity: Name: NameFull: Nahas M – PersonEntity: Name: NameFull: Ma Y – PersonEntity: Name: NameFull: Torres D – PersonEntity: Name: NameFull: Saldarriaga I – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Arruda de Amaral A – PersonEntity: Name: NameFull: Ploumakis A – PersonEntity: Name: NameFull: Clohessy J – PersonEntity: Name: NameFull: Abirached J – PersonEntity: Name: NameFull: Bisharat L – PersonEntity: Name: NameFull: Fraenkel P – PersonEntity: Name: NameFull: Yildirim O – PersonEntity: Name: NameFull: Bonnevaux H – PersonEntity: Name: NameFull: Guerif S – PersonEntity: Name: NameFull: Rallis K – PersonEntity: Name: NameFull: Chedid G – PersonEntity: Name: NameFull: Kufe D – PersonEntity: Name: NameFull: Vlachos IS – PersonEntity: Name: NameFull: Avigan D – PersonEntity: Name: NameFull: Rosenblatt J IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 11 Text: 2025 Nov 11 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 9 – Type: issue Value: 21 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |